TREATING HORROR WITH ECSTASY : Neurobiological Rationale for Treating Post- Traumatic Stress Disorder with 3,4- methylenedioxymethylamphetamine
Post-traumatic stress disorder (PTSD) is a disabling condition that afflicts 1-10% of the general population, with twice as high lifetime prevalence for women than men. Treatments exist, but none have proven reliable and consistent efficacy. A large minority of patients remain treatment-resistant de...
Main Author: | Agelii, Anna |
---|---|
Format: | Others |
Language: | English |
Published: |
Högskolan i Skövde, Institutionen för kommunikation och information
2013
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-8298 |
Similar Items
-
High Performance Thin Layer Chromatography method for analysis of 3,4-methylenedioxymethamphetamine in seized tablets
by: Boris E. Duffau, et al.
Published: (2015-12-01) -
Ecstasy-Induced Malignant Hyperthermia with Fatal Outcome: A Case Report
by: Rybarova V, et al.
Published: (2021-03-01) -
Determining the purity of ecstasy (MDMA): strategies utilized by recreational ecstasy users in Victoria, British Columbia
by: Callas, Melanie
Published: (2016) -
Acute ascending aortic dissection after MDMA/ecstasy use: A case report
by: Satoko Kanahara, MD, et al.
Published: (2016-09-01) -
The subchronic effects of 3,4-methylendioxymethamphetamine on oxidative stress in rat brain
by: Simić Ivan, et al.
Published: (2014-01-01)